These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33117604)

  • 21. A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer.
    Cao B; Luo L; Feng L; Ma S; Chen T; Ren Y; Zha X; Cheng S; Zhang K; Chen C
    BMC Cancer; 2017 Dec; 17(1):844. PubMed ID: 29237416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma.
    Wu M; Li X; Liu R; Yuan H; Liu W; Liu Z
    J Cancer; 2020; 11(21):6299-6318. PubMed ID: 33033514
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma.
    Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q
    Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
    Shen R; Liu B; Li X; Yu T; Xu K; Ma J
    BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
    Qi X; Qi C; Qin B; Kang X; Hu Y; Han W
    Front Oncol; 2020; 10():541330. PubMed ID: 33072571
    [No Abstract]   [Full Text] [Related]  

  • 26. Identification and validation of a novel overall survival prediction model for immune-related genes in bone metastases of prostate cancer.
    Bi W; Guo W; Fan G; Xie L; Jiang C
    Aging (Albany NY); 2023 Jul; 15(14):7161-7186. PubMed ID: 37494663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of an immune gene prognostic classifier for survival prediction and respond to immunocheckpoint inhibitor therapy/chemotherapy in endometrial cancer.
    Liu J; Chen X; Jiang Y; Cheng W
    Int Immunopharmacol; 2020 Sep; 86():106735. PubMed ID: 32619957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive Analysis of Tumor-Infiltrating Immune Cells and Relevant Therapeutic Strategy in Esophageal Cancer.
    Lu G; Chen L; Wu S; Feng Y; Lin T
    Dis Markers; 2020; 2020():8974793. PubMed ID: 32454908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for fluoropyrimidine-induced cardiotoxicity in colorectal cancer: A retrospective cohort study and establishment of a prediction nomogram for 5-FU induced cardiotoxicity.
    Wang Y; Wang W; Dong H; Wang G; Chen W; Chen J; Chen W
    Front Oncol; 2023; 13():1017237. PubMed ID: 36937428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model.
    Pang Z; Chen X; Wang Y; Wang Y; Yan T; Wan J; Du J
    Int Immunopharmacol; 2020 Sep; 86():106744. PubMed ID: 32623229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer.
    Ge P; Wang W; Li L; Zhang G; Gao Z; Tang Z; Dang X; Wu Y
    Biomed Pharmacother; 2019 Oct; 118():109228. PubMed ID: 31351430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low tumor infiltrating mast cell density confers prognostic benefit and reflects immunoactivation in colorectal cancer.
    Mao Y; Feng Q; Zheng P; Yang L; Zhu D; Chang W; Ji M; He G; Xu J
    Int J Cancer; 2018 Nov; 143(9):2271-2280. PubMed ID: 29873076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancer.
    Tian X; Zhu X; Yan T; Yu C; Shen C; Hu Y; Hong J; Chen H; Fang JY
    Mol Oncol; 2017 Nov; 11(11):1544-1560. PubMed ID: 28796930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A model based on tumor-infiltrating immune cells for predicting the relapse rates of patients with testicular germ cell tumors.
    Wang Y; Ji C; Liu J; Wang Y; Song N; Cao P
    Int Immunopharmacol; 2020 Sep; 86():106710. PubMed ID: 32652500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitophagy-related gene signature predicts prognosis, immune infiltration and chemotherapy sensitivity in colorectal cancer.
    Weng JS; Huang JP; Yu W; Xiao J; Lin F; Lin KN; Zang WD; Ye Y; Lin JP
    World J Gastrointest Oncol; 2023 Mar; 15(3):546-561. PubMed ID: 37009318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
    Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
    Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival.
    Chen RL; Zhou JX; Cao Y; Sun LL; Su S; Deng XJ; Lin JT; Xiao ZW; Chen ZZ; Wang SY; Lin LZ
    Front Immunol; 2020; 11():1933. PubMed ID: 33072067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A gene expression-based study on immune cell subtypes and glioma prognosis.
    Zhong QY; Fan EX; Feng GY; Chen QY; Gou XX; Yue GJ; Zhang GH
    BMC Cancer; 2019 Nov; 19(1):1116. PubMed ID: 31729963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of prognostic immune-related signature predicting the overall survival for colorectal cancer.
    Bai J; Zhang X; Xiang ZX; Zhong PY; Xiong B
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1134-1141. PubMed ID: 32096169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
    Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.